Unaudited Financial Results for the quarter ended 30.06.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 1.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gayatri BioOrganics announced its Q1 FY26 unaudited results, approved at the board meeting held on 29 July 2025. The company also approved the 34th Directors' Report and Notice for the 34th Annual General Meeting, scheduled for 26 August 2025 via video conferencing. Financial figures in the statement indicate losses for both the quarter and the prior year (figures shown in brackets). Note 3 in the results explicitly states that the financials have been prepared on a going concern basis based on a comfort letter from the promoters, signalling reliance on promoter support. The auditor MGR & Co issued an unqualified limited review report with no qualifications or emphasis of matter.
The explicit going-concern disclosure tied to promoter comfort letters, combined with apparent quarterly losses, is a significant red flag for shareholders. While the auditor's review is clean, investors should weigh the company's dependence on promoter support and weak profitability before making decisions.